Allan Goldstein believes the thymosins he discovered can cure immune diseases, and he hopes his company and institute will prove it WASHINGTON--Science moves too slowly for biochemist Allan Goldstein. For most of his professional life, he has been trying to unravel the mysteries of the human immune system through a better understanding of a group of hormones known as thymosins. He discovered them 26 years ago, and their use in 1974 to save the life of a five-year-old girl, along with his encou
Allan Goldstein believes the thymosins he discovered can cure immune diseases, and he hopes his company and institute will prove it |
Goldstein has been impatient for much of his career, however, with the type of slow, steady progress that his NIH grant would permit. In 1980 the chairman of the biochemistry department of George Washington University in Washington, D.C., took out a $100,000 bank loan and ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.
An improved chromatography membrane elution method helps scientists achieve higher yields of pure plasmid DNA.
By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.
Discover a scalable and flexible GMP-compliant workflow for producing plasmid DNA.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling
Redefining Lab Vacuum with Efficiency, Flexibility, and Sustainability
